Uncategorized
Fortive Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Latest Ratings for FTV Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Credit Suisse Maintains Outperform Jan 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for FTV View the Latest Analyst Ratings read more
8 Analysts Assess Ameresco: What You Need To Know
Latest Ratings for AMRC Date Firm Action From To Mar 2022 B of A Securities Maintains Buy Mar 2022 Stifel Maintains Buy Mar 2022 Raymond James Maintains Outperform View More Analyst Ratings for AMRC View the Latest Analyst Ratings read more
4 Analysts Assess Controladora Vuela: What You Need To Know
Latest Ratings for VLRS Date Firm Action From To Feb 2022 Barclays Maintains Overweight Feb 2022 Credit Suisse Upgrades Neutral Outperform Jul 2021 B of A Securities Initiates Coverage On Buy View More Analyst Ratings for VLRS View the Latest Analyst Ratings read more
What 16 Analyst Ratings Have To Say About T. Rowe Price Group
Latest Ratings for TROW Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Deutsche Bank Maintains Hold Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for TROW View the Latest Analyst Ratings read more
Marvell Technology Stock Is Falling After The Bell: What’s Happening?
Marvell Technology shares are sliding in Tuesday’s after-hours session after the company postponed its Investor Day, citing a dynamic macroeconomic environment. read more
Arista Networks Shares Fall After Mixed Q1 Results: EPS Beat, Revenues Miss, Q2 Guidance Below Estimates
Arista Networks released its first-quarter results after Tuesday’s closing bell. Here’s a look at the key details from the quarter. read more
Lineage Stock Forecast Slashed By 30% – Here’s Why
Analyst downgraded LINE, lowered price target due to revenue challenges, supply chain issues, & earnings revisions. 2025 outlook maintained. Latest Ratings for LINE Date Firm Action From To Mar 2016 Goldman Sachs Terminates Coverage On Sell Feb 2016 Wells Fargo Downgrades Market Perform Underperform Feb 2016 Citigroup Downgrades Neutral Sell View More Analyst Ratings for…
Navitas GaN Adoption Is Slower Than Anticipated: Analyst
Analyst revises estimates for NVTS after in line Q1 results, with $14.02M sales beating estimated $13.99M. Q2 sales expected at $14M-$15M vs consensus $14.95M. Latest Ratings for NVTS Date Firm Action From To Feb 2022 Rosenblatt Initiates Coverage On Buy Feb 2022 Needham Initiates Coverage On Buy Dec 2021 B of A Securities Initiates Coverage…